Page last updated: 2024-10-28

hydroxychloroquine and Paraneoplastic Syndromes

hydroxychloroquine has been researched along with Paraneoplastic Syndromes in 5 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.

Research Excerpts

ExcerptRelevanceReference
"However, DM without muscle weakness is a clinical entity with respect to favorable long-term prognosis."1.29Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. ( Amaudric, F; Cosnes, A; Gherardi, R; Revuz, J; Roujeau, JC; Verroust, J; Wechsler, J, 1995)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inhoff, O1
Peitsch, WK1
Paredes, BE1
Goerdt, S1
Goebeler, M1
Chaudhry, SI1
Murphy, LA1
White, IR1
Aslanidis, S1
Pyrpasopoulou, A1
Kartali, N1
Zamboulis, C1
Cosnes, A1
Amaudric, F1
Gherardi, R1
Verroust, J1
Wechsler, J1
Revuz, J1
Roujeau, JC1
Brenner, S1
Golan, H1
Gat, A1
Bialy-Golan, A1

Reviews

2 reviews available for hydroxychloroquine and Paraneoplastic Syndromes

ArticleYear
Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis?
    Clinical and experimental dermatology, 2005, Volume: 30, Issue:6

    Topics: Carcinoma, Squamous Cell; Dermatologic Agents; Humans; Hydroxychloroquine; Laryngeal Neoplasms; Lupu

2005
Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung.
    Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:2

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti

1997

Other Studies

3 other studies available for hydroxychloroquine and Paraneoplastic Syndromes

ArticleYear
Simvastatin-induced amyopathic dermatomyositis.
    The British journal of dermatology, 2009, Volume: 161, Issue:1

    Topics: Aged; Biopsy; Dermatomyositis; Female; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reducta

2009
Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
    Clinical rheumatology, 2007, Volume: 26, Issue:7

    Topics: Adult; Dermatomyositis; Drug Therapy, Combination; Exanthema; Female; Glucocorticoids; Humans; Hydro

2007
Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids.
    Archives of dermatology, 1995, Volume: 131, Issue:12

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Case-Control Studies; Child;

1995